LGALS14, galectin 14, 56891

N. diseases: 35; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.020 Biomarker disease BEFREE Further studies evaluating other phenotypes associated with CF may be useful in the future to assess the ability of CLC-2 to modify CF disease severity. 15507145 2004
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.020 Biomarker disease BEFREE The ClC-2 Cl- channel is thus a potential target for therapy in cystic fibrosis. 11401826 2001